Australia Peripheral Vascular Devices Market Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview
The Australia Peripheral Vascular Devices Market is anticipated to grow from USD 75.14 million in 2023 to USD 128.02 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.89%.
Growth in this market is primarily fueled by the rising incidence of peripheral artery disease (PAD) and an expanding elderly population more vulnerable to vascular conditions. Advancements in technology—particularly in minimally invasive procedures and advanced imaging techniques—are further accelerating market development. The demand for effective treatment solutions and improvements in healthcare infrastructure are also contributing to market expansion. Increased awareness of peripheral vascular diseases, along with the availability of sophisticated diagnostic tools, is encouraging broader adoption of vascular devices. A growing preference for outpatient procedures and favorable changes in reimbursement frameworks are enhancing device utilization. Emerging trends such as bioresorbable vascular scaffolds, innovative stent technologies, and non-invasive treatment alternatives are expected to influence future market dynamics. Government initiatives aimed at strengthening healthcare accessibility and enhancing vascular disease management are further supporting market growth.
Market Drivers
Increasing Incidence of Peripheral Artery Disease (PAD)
The growing prevalence of Peripheral Artery Disease (PAD) in Australia is a key factor driving demand for peripheral vascular devices. PAD, characterized by arterial narrowing due to plaque buildup, is increasingly common among the aging population and those affected by smoking, diabetes, and hypertension. Studies suggest PAD affects up to 10% of patients in primary care and over 20% of individuals aged 75 and older. The escalating number of PAD cases is heightening the need for diagnostic and therapeutic vascular devices, thereby contributing significantly to market expansion.
Market Challenges Analysis
High Costs and Complex Reimbursement Structures
A significant challenge confronting the Australia peripheral vascular devices market is the high cost associated with advanced treatment options. Devices such as stents, catheters, and diagnostic imaging systems require considerable investment from both healthcare providers and patients. Although public healthcare coverage exists for many interventions, reimbursement for certain high-end devices remains inconsistent and complex. According to the Medical Technology Association of Australia (MTAA), reimbursement mechanisms can vary widely, affecting the economic feasibility for providers, particularly in rural settings. These disparities can hinder the timely adoption of innovative technologies. Additionally, variations in insurance coverage add to affordability issues, limiting patient access to necessary vascular treatments.
Market Segmentation
By Device Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Guidewires
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Region:
New South Wales
Victoria
Queensland
Western Australia (WA)
South Australia
Key Player Landscape
Terumo Corporation
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Nipro Corporation
Cook Medical
Asahi Intecc Co., Ltd.
B. Braun Melsungen AG
MicroPort Scientific Corporation
Cardinal Health
The Australia Peripheral Vascular Devices Market is anticipated to grow from USD 75.14 million in 2023 to USD 128.02 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.89%.
Growth in this market is primarily fueled by the rising incidence of peripheral artery disease (PAD) and an expanding elderly population more vulnerable to vascular conditions. Advancements in technology—particularly in minimally invasive procedures and advanced imaging techniques—are further accelerating market development. The demand for effective treatment solutions and improvements in healthcare infrastructure are also contributing to market expansion. Increased awareness of peripheral vascular diseases, along with the availability of sophisticated diagnostic tools, is encouraging broader adoption of vascular devices. A growing preference for outpatient procedures and favorable changes in reimbursement frameworks are enhancing device utilization. Emerging trends such as bioresorbable vascular scaffolds, innovative stent technologies, and non-invasive treatment alternatives are expected to influence future market dynamics. Government initiatives aimed at strengthening healthcare accessibility and enhancing vascular disease management are further supporting market growth.
Market Drivers
Increasing Incidence of Peripheral Artery Disease (PAD)
The growing prevalence of Peripheral Artery Disease (PAD) in Australia is a key factor driving demand for peripheral vascular devices. PAD, characterized by arterial narrowing due to plaque buildup, is increasingly common among the aging population and those affected by smoking, diabetes, and hypertension. Studies suggest PAD affects up to 10% of patients in primary care and over 20% of individuals aged 75 and older. The escalating number of PAD cases is heightening the need for diagnostic and therapeutic vascular devices, thereby contributing significantly to market expansion.
Market Challenges Analysis
High Costs and Complex Reimbursement Structures
A significant challenge confronting the Australia peripheral vascular devices market is the high cost associated with advanced treatment options. Devices such as stents, catheters, and diagnostic imaging systems require considerable investment from both healthcare providers and patients. Although public healthcare coverage exists for many interventions, reimbursement for certain high-end devices remains inconsistent and complex. According to the Medical Technology Association of Australia (MTAA), reimbursement mechanisms can vary widely, affecting the economic feasibility for providers, particularly in rural settings. These disparities can hinder the timely adoption of innovative technologies. Additionally, variations in insurance coverage add to affordability issues, limiting patient access to necessary vascular treatments.
Market Segmentation
By Device Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Guidewires
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Region:
New South Wales
Victoria
Queensland
Western Australia (WA)
South Australia
Key Player Landscape
Terumo Corporation
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Nipro Corporation
Cook Medical
Asahi Intecc Co., Ltd.
B. Braun Melsungen AG
MicroPort Scientific Corporation
Cardinal Health
Table of Contents
200 Pages
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. Australia Peripheral Vascular Devices Market Snapshot
- 2.1.1. Australia Peripheral Vascular Devices Market, 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : Australia Peripheral Vascular Devices Market – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. Australia Peripheral Vascular Devices Market Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups / SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : Australia Peripheral Vascular Devices Market – BY Based on Type: ANALYSIS
- CHAPTER NO. 7 : Australia Peripheral Vascular Devices Market – BY Based on End-user: ANALYSIS
- CHAPTER NO. 8 : Australia Peripheral Vascular Devices Market – ANALYSIS
- CHAPTER NO. 9 : COMPANY PROFILES
- 9.1. Terumo Corporation
- 9.1.1. Company Overview
- 9.1.2. Product Portfolio
- 9.1.3. SWOT Analysis
- 9.1.4. Business Strategy
- 9.1.5. Financial Overview
- 9.2. Medtronic plc
- 9.3. Boston Scientific Corporation
- 9.4. Abbott Laboratories
- 9.5. Nipro Corporation
- 9.6. Cook Medical
- 9.7. Asahi Intecc Co., Ltd.
- 9.8. B. Braun Melsungen AG
- 9.9. MicroPort Scientific Corporation
- 9.10. Cardinal Health
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
